351490-85-2

Basic information

• Product Name: 1H-Indene-2-ethanaMine, 2,3-dihydro-.alpha.,.alpha.-diMethyl-
• Synonyms: 1H-Indene-2-ethanaMine, 2,3-dihydro-.alpha.,.alpha.-diMethyl-;1-(2,3-dihydro-1H-inden-2-yl)-2-Methylpropan-2- aMine;1-(2,3-dihydro-1H-inden-2-yl)-2-Methylpropan-2- aMine hydrochloride
• CAS NO: 351490-85-2
• Molecular Formula: C₁₃H₁₉N
• Molecular Weight: 189.29666
• EINECS: 928-267-7
• Mol File: 351490-85-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 288.2±9.0 °C(Predicted)
• Appearance: /
• Density: 0.981±0.06 g/cm3(Predicted)
• PKA: 10.53±0.25(Predicted)
• CAS DataBase Reference: 1H-Indene-2-ethanaMine, 2,3-dihydro-.alpha.,.alpha.-diMethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indene-2-ethanaMine, 2,3-dihydro-.alpha.,.alpha.-diMethyl-(351490-85-2)
• EPA Substance Registry System: 1H-Indene-2-ethanaMine, 2,3-dihydro-.alpha.,.alpha.-diMethyl-(351490-85-2)

Safety Data

• Hazardous Substances Data: 351490-85-2(Hazardous Substances Data)

Usage

General Description

1H-Indene-2-ethanamine, 2,3-dihydro-.alpha.,.alpha.-dimethyl- is a chemical compound with the molecular formula C13H17N. It is also known as 2,3-dihydro-1H-indene-2-ethanamine and is classified as an amine. 1H-Indene-2-ethanamine, 2,3-dihydro-.alpha.,.alpha.-dimethyl- is characterized by the presence of a 2,3-dihydro-1H-indene core with an attached ethanamine group and two alpha, alpha-dimethyl substituents. It has potential applications in the field of organic chemistry, pharmaceuticals, and research due to its unique structural characteristics and chemical properties. Further studies and investigations are needed to fully understand its potential uses and effects.

Upstream product

• 53273-37-3 indan-2-yl-acetic acid methyl ester 
• 351490-86-3 1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-ol 
• 37868-26-1 2-(indan-2-yl)acetic acid 
• 351490-87-4 N-(1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl)acetamide 

Downstream Products

• 351490-26-1 SB-423557 
• 862992-95-8 3-bromo-2-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-benzonitrile 
• 862992-88-9 (R)-1-(6-bromo-2,3-difluoro-phenoxy)-3-(2-indan-2-yl-1,1-dimethylethylamine)-propan-2-ol 
• 1232402-91-3 3-{2-[(1R)-1-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}ethyl]phenyl}propanoic acid 
• 1232407-05-4 methyl 3-{2-[(1R)-1-({(5R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]-2-oxo-1,3-oxazolidin-5-yl}methoxy)ethyl]phenyl}-2,2-dimethylpropanoate 
• 1232407-04-3 Methyl 3-(2-[(1R)-1-({(5R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]-2-oxo-1,3-oxazolidin-5-yl}methoxy)ethyl]phenyl}-2-methylpropanoate 
• 1232407-03-2 methyl 3-{2-[(1R)-1-({(5R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]-2-oxo-1,3-oxazolidin-5-yl}methoxy)ethyl]phenyl}propanoate 
• 1232407-01-0 3-{2-[(1R)-1-{[(2R)-3-{[1-(2,3-Dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}ethyl]phenyl}-2,2-dimethylpropanoic acid 
• 1232402-97-9 methyl 3-{2-[(1R)-1-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}ethyl]phenyl}propanoate 
• 1035154-06-3 ethyl 3-[3-((1S)-2-{[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino}-1-hydroxyethyl)-4,5-difluorophenyl]propanoate 
• 702687-43-2 (R)-1-(5-bromo-2,3-difluoro-phenoxy)-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propan-2-ol 

Relevant articles and documents

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS

Novel tricyclic compounds of Formula (I) and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor antagonists. Pharmaceutical compositions and methods of treatment are also included.

SULFONAMIDE COMPOUNDS AND THE USE

The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.

Calcilytic compounds

Novel calcilytic compounds and methods of using them are provided.